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The aim of this study was to investigate the influence of hyperbaric oxygenation treatment
(HBOT), a potent inhibitor of tissue hypoxia, on the motor activity and the spinal cord tissue
concentration of free palmitic (C16:0), stearic (C18:0), oleic (C18:1n-9), arachidonic (C20:4n-6)
and docosahexaenoic (C22:6n-3) acids, in rabbits with spinal cord injury (SCI). SCI resulted in
paraplegia and accumulation of all analyzed free fatty acids (FFAs) in the spinal cord after
neurotrauma. HBOT (222.915 kPa pressure of 99.5 % oxygen for 45 min), applied immedi-
ately after injury and followed by 8 consecutive daily treatments, improved motor impairment
and completely prevented the SCI-induced increase in FFAs. These data suggest that a pertur-
bation of the membrane lipid metabolism may contribute to the functional deficit associated
with SCI, and HBOT may protect the injured spinal cord tissue, at least in part, by limiting






* Dedicated to Professor @eljko Ku}an on the occasion of his 70th birthday. Presented at the Congress of the Croatian Society of
Biochemistry and Molecular Biology, HDBMB2004, Bjelolasica, Croatia, September 30 – October 2, 2004.
** Author to whom correspondence should be addressed. (E-mail: prado@mamed.medri.hr)
CROATICA CHEMICA ACTA





Fatty acids are components of membrane phospholipids,
playing an important role in maintaining the structure
and function of the cell membrane. A severe impact spi-
nal cord injury (SCI) results in a decrease in total
phospholipid content of the spinal nerve tissue for up to
three days following injury,1 but no major class of
phospholipids is selectively hydrolyzed.1–4
Such impact injury to the spinal cord is associated
with a biphasic increase in spinal cord free fatty acid
(FFA) levels.1 The initial increase observed within 5 min
of SCI is followed by a decline 30 min after the injury.
The secondary increase, appearing one hour after the
SCI, is more persistent. It peaks 24 h post trauma and
declines over the following six days.1 Due to the specific
phospholipid composition of neurons, free arachidonic
acid (AA, C20:4) is reported to be the primary fatty acid
released as a result of injury-mediated tissue damage.
Murphy and co-workers have proposed that a release of
FFAs, in particular AA, may not always involve general
membrane degradation but rather an up-regulation
and/or overstimulation of phospholipase (PL) A2 linked
membrane receptors.5 Release of FFAs, due to the acti-
vation of membrane PLs and lipases,6–8 is one of the first
pathophysiological events that follows primary trauma of
the spinal cord, independent of the type of injury.1–3,9,10
FFAs, and AA in particular, may lead to a secondary da-
mage to spinal cord neurons by inducing oxidative stress
or increasing the intracellular calcium level.11 Additio-
nally, AA plays a significant role in the cell trauma by
being a precursor for prostaglandin and leukotriene syn-
thesis.12
Major factors contributing to the secondary tissue
damage include a release of neurochemicals, impairment
of the microcirculation, increase of vascular permeabil-
ity, formation of oedema and tissue hypoxia.13,14 It
seems likely that these phenomena are interrelated in a
complex way and that early modification of any of these
factors might influence the others.14
Hyperbaric oxygenation treatment (HOBT) involves
intermittent inhalation of 100 % oxygen under pressure
higher than 1 atm (101.325 kPa).15 Physiologically, this
produces a directly proportional increase in the plasma
volume fraction of transported oxygen, which is readily
available for cellular metabolism.16 The blood oxygen
concentration at sea level is 0.3 ml/dl.17,18 Tissues at rest
extract 5 to 6 ml O2/dl blood, assuming normal perfu-
sion.17,19 Administering 100 % oxygen at ambient pres-
sure increases the amount of oxygen dissolved in the
blood fivefold to 1.5 ml/dl, and at 3 atm (303.975 kPa)
the dissolved oxygen content is approximately 6 ml/dl,17
more than enough to meet the resting cells requirements
without any contribution from oxygen bound to haemo-
globin.20 Thus, HBOT could sustain life without circu-
lating haemoglobin.18
HBOT has been tested in various animal21–24 and cli-
nical studies.25–29 It is the primary therapy for arterial gas
embolism, decompression sickness, exceptional blood-
loss anaemia and severe carbon monoxide poisoning, and
adjunctive therapy for Clostridial myconecrosis, com-
promised skin grafts and osteoradionecrosis preven-
tion.20 HBOT is still under discussion30 as adjunctive
treatment for several clinical indications, such as stroke
and brain trauma,31,32 refractory osteomyelitis, selected
problem wounds (diabetic and pressure ulcers), radia-
tion-induced soft tissue injury, radiation-induced hemor-
rhagic cystitis, necrotizing fascitis, crush injury, com-
partment syndromes, acute traumatic peripheral ischemia,
cerebrovasular accidents, head injury, spinal cord injury,
retinal artery insufficiency, optic neuritis, fracture heal-
ing and bone grafts.20,24,33 It has been shown to diminish
the infarct size in focal cerebral ischemia34 without sec-
ondary injuries due to oxidative stress,35 and to prevent a
decline in Na+, K+- ATPase activity in global cerebral
ischemia-exposed rats.36
Even though extensive clinical experience with
HBOT has proven to be beneficial, the exact biochemi-
cal mechanism is not clear.
The aim of this study was to examine the influence




The study was carried out on adult Hila rabbits, of both sexes,
weighing 2.5–3.0 kg. They were obtained 3.5 months old
from the Rabbit Heaven farm (Sesvete, Croatia). The ani-
mals were maintained on a 12 h light-dark cycle and allow-
ed free access to food and water. All experiments were per-
formed between 10:00 h and 12:00 h in a silent room, at a
temperature of 22–24 oC. All animals were handled accord-
ing to the guidelines of the Society of Neuroscience,37 and
all animal use procedures were approved by the Faculty
Ethical Committee.
The animals were randomly divided into four experi-
mental groups (n = 6): control group SHAM (sham-oper-
ated, laminectomized animals, without spinal cord injury),
control group INJURY (laminectomized animals with spinal
cord injury), control group SHAM-HBOT (laminectomized,
HBOT-treated animals) and experimental INJURY-HBOT
group (animals with spinal cord injury, HBOT-treated) (Ta-
ble I).
After the injury and/or laminectomy, rabbits were indi-
vidually housed and their bladders were emptied by manual
compression daily. Hind limb motor activity was controlled
daily over the course of the nine post-operating days and
scored according to Tarlov’s38 system. The measures were
performed blindly. Hind limb function was graded using a
five-point ordinal scale as follows: 1 = complete paralysis;
2 = minimal functional movement; 3 = movement of legs,
does not support weight; 4 = hopping, partially impaired; 5
= normal motor function.
Rabbits were monitored for 9 postoperative days be-
cause a spinal shock lasts for 5 to 7 days.32
At the end of the experiment, on the ninth post-opera-
tion day, animals were killed (following the recommenda-
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TABLE I. Distribution of animals to experimental groups(a)
Control SHAM Control INJURY Control SHAM-HBOT Experimental INJURY-HBOT
HBOT for 9 days + +
Laminectomy only + +
Laminectomy + spinal cord injury + +
(a) n = 6 per group.
tions for euthanasia of experimental animals);39 the spinal
cord was traversed and removed from the spinal canal, and
as soon as possible frozen in liquid nitrogen and prepared at
–84 oC for further analysis. Spinal cord samples were taken
at the level of the second lumbar vertebra (L2).
Spinal Cord Injury
Medial dorsal lumbar laminectomy in rabbits was perform-
ed under pentobarbital sodium anesthesia (30 mg/kg intra-
venously) using the modified technique of Albin et al.40 The
vertebral column was exposed in the upper lumbar region
and a one-segment laminectomy was performed at the level
of the second lumbar vertebra (L2). In twelve animals, la-
minectomy was followed by contusion of the spinal cord,
provoked by a strike of 150 g cm, which resulted in a spon-
taneously irreversible paraplegia. Namely, a tapered weight
of 12.5 g was dropped from a height of 120 mm onto the
exposed spinal cord, striking it with a force of 150 g cm,
and producing paraplegia detected as a significant spinal
cord evoked potential waveform abnormality. After the con-
trolled SCI, the wound was completely sutured with the mus-
cle and skin. Each traumatized animal received 500 000 IU
(100 IU  60 g) of benzyl penicillin. During the following
nine post-operation days the general status, degree of in-
jury, and the appearance of the wound were controlled.
Hyperbaric Oxygenation
Non-traumatized rabbits (SHAM-HBOT group) were ex-
posed to HBOT once daily for nine days after laminectomy,
lasting 45 minutes. The pressure in the HBO chamber was
222.915 kPa (2.2 bar) with a constant flow of 99.5 ± 0.5 %
oxygen (Montkemija, Bakar, Croatia). The INJURY-HBOT
group of rabbits was submitted to HBOT immediately after
the injury and for the eight subsequent days, under the
same conditions (Figure 1).
Constant flushing of the chamber atmosphere with oxy-
gen at a rate of 10 l/min and Sofnolime granules (Molecular
Products, Thaxted, Essex, UK), spread in a canister on the
bottom of the chamber, successfully prevented CO2 accu-
mulation in the chamber atmosphere. The oxygen content
was monitored continuously and maintained at  98.5 %
(OxymeterTM, Dräger, Lübeck, Germany). The CO2 con-
centration was not allowed to rise above 0.1 %. An envi-
ronmental control system maintained the inner temperature
and relative humidity at 25 ± 1 oC and 50 ± 20 %, respec-
tively. After the HBOT, the chamber was decompressed
within 5 min in order to prevent pulmonary barotrauma in
the animals.41
Free Fatty Acids
Total lipids were extracted from the spinal cord tissue by
the modified method of Folch et al.42 Frozen samples were
weighed (200–400 mg) and homogenized in 10 mL of a
chloroform-methanol (vol. ratio 2:1) mixture (Ultrasonic
Fisher Scientific, Model 60, three times for 3 min at 5000
rpm). Nonadecanoic acid (C19:0) was added as an internal
standard in all samples and the antioxidant butylated hydro-
xytoluene (BHT) was added at 50 mg/L in all solvents.
Homogenates were left overnight at 4 °C. After filtration, 2
mL of 0.034 % MgCl2 aqueous solution was added. The
mixture was well mixed and left at 4 °C overnight. Water
and organic phases were separated and the lower, organic
phase was evaporated to dryness under N2 gas. Total lipid
extract was weighed and dissolved in 1 mL of the chloro-
form-methanol (2:1) mixture.
The FFAs were separated by preparative two step thin-
layer chromatography on silica gel plates (Silicagel 60 F254;
Merck, Darmstadt, Germany, 20  20 cm, 0.2 mm) using the
following developing solvents: petroleum ether-ether-acetic
acid (vol. ratio 97:3:1) and petroleum ether-ether-acetic
acid (vol ratio 80:20:1). Streaks on thin-layer plates were
detected under a UV lamp and scraped off.
FFA methyl esters were prepared by methylation with a
BF3-methanol (3.0 mL, 14 % mixture; 90 min, 100 oC),43
water was added, the mixture was extracted with petroleum
ether, and quantified by gas chromatography using the
C19:0 as internal standard. Identification was done by com-
parison with commercial fatty acid methyl ester standards
(Sigma-Aldrich, Germany).
The fatty acid gas chromatography analysis was perform-
ed on the Perkin-Elmer, Model 8410 gas chromatograph
with FID detector using a metal column (diameter  = 1/2
in, length 3 m) packed with 10 % FFAP on Chromosorb W.
H P. 80–100 mesh, flow 30 mL/min.
Chloroform used for GC was SupraSolv purchased from
Merck (Germany). All other reagents were of GR grade
(Kemika, Croatia).
Data Analysis
The values are expressed as means ± S.E.M. of six rabbits.
Analyses of variance (ANOVA) were performed at the
p  0.05 level to compare the results of different treatments.
The Tukey HSD test was used post hoc.
RESULTS
Effect of Spinal Cord Injury
Untreated, sham-operated rabbits (SHAM) exhibited mild
and temporary disturbances in moving their hind legs on
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Figure 1. Schematic representation of the experimental protocol.
The SHAM-HBOT and INJURY-HBOT groups of rabbits were placed
into the experimental hyperbaric chamber immediately after opera-
tion (laminectomy or injury) and during eight post-operative days.
the first and second postoperative days. These symptoms
completely disappeared on the third postoperative day.
Contusion of the spinal cord provoked by a strike of
150 g cm resulted in a spontaneously irreversible para-
plegia in the experimental animals. As a result, a
statistically significant difference during the whole test-
ing period was observed between untreated, sham-oper-
ated rabbits (SHAM) and untreated rabbits with spinal
cord trauma (INJURY) (Figure 2).
Figure 3 shows the effect of spinal cord injury on the
level of FFAs in spinal cord tissue in untreated rabbits.
In comparison with sham-operated animals (SHAM),
spinal cord injury (INJURY) was associated with a sta-
tistically significant increase in all examined FFAs: free
palmitic (C16:0), stearic (C18:0), oleic (C18:1n-9), ara-
chidonic (C20:4n-6) and docosahexaenoic acids (C22:
6n-3).
Effect of HBOT
Treatment with HBOT had no influence on motor activ-
ity (Figure 4) or the FFA levels in the animals with la-
minectomy only (SHAM-HBOT vs. SHAM) (Figure 5).
Figure 6 presents the motor activity of untreated and
HBOT rabbits with spinal cord injury (INJURY-HBOT
vs. INJURY). ANOVA revealed a significant beneficial
effect of HBOT and post-hoc analysis showed that mo-
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Figure 2. Motor activity (Tarlov's units) in animals of Control SHAM
and Control INJURY during nine post-operative days. *p<0.05:
























Figure 3. Effects of experimental impact injury on the level of FFAs
in the rabbit spinal cord tissue. Values are expressed as mg FFA/g
wet tissue, given by methyl esters of fatty acids after separation by
gas chromatography, using nonadecanoic acid (C19:0) as internal
standard. Only major components are shown: palmitic (C16:0),
stearic (C18:0), oleic (C18:1), arachidonic (C20:4) and docosa-
hexaenoic (C22:6) acids in laminectomized (SHAM) and injured
(INJURY) rabbits. Each column represents mean ± S.E.M.; n = 6
for each group. *p<0.05: significantly different from control group
SHAM.
Figure 4. Motor activity (Tarlov's units) of laminectomized SHAM ani-
mals treated with HBOT during nine post-operative days. *p<0.05:





















Figure 5. Levels of free palmitic (C16:0), stearic (C18:0), oleic
(C18:1), arachidonic (C20:4) and docosahexaenoic (C22:6) acids
(mg/g tissue) in the control group SHAM and the group treated with
hyperbaric oxygen (SHAM-HBOT) (223 kPa, 45 min) 9 days after
laminectomy. Each column represents mean ± S.E.M.; n = 6 for
each group. *p<0.05: significantly different from Control SHAM.
Figure 6. Motor activity (Tarlov's units) of injured animals treated
with HBOT during nine post-operative days. (INJURY vs. INJURY-
HBOT). *p<0.05: significantly different from control group (INJURY).
tor activity was improved in all groups receiving HBOT
compared to the untreated group with SCI.
HBOT resulted in a decrease in free palmitic F(1,9) =
138.33; p < 0.001, stearic F(1,9) = 139.04; p < 0.001,
oleic F(1,9) = 341.49; p < 0.001, arachidonic F(1,9) =
95.15; p < 0.001 and docosahexaenoic F(1,9) =
216.63; p < 0.001 acids in the rabbit spinal cord tissue
samples (Figure 7). F is the variance ratio (defined as
the ratio of two independent estimates of variance).
DISCUSSION
In this study, as expected, SCI resulted in motor distur-
bances and accumulation of FFAs at the injury site. The
data correlates well with previously published re-
ports.1–3,5,44–46
Loss or decrease of motor activity is the most promi-
nent and the most functionally relevant result of spinal
cord injury.40 Motor disturbances observed in the rabbits
that experienced trauma in response to the force of 150
g cm were not a result of the laminectomy procedure.
Symptoms of the injured animals differed significantly
from the mild and temporary symptoms observed in the
group that was only laminectomized.
Following impact trauma, the spinal cord undergoes
a progressive series of auto-destructive pathological
changes.2,3,47 A significant loss of motor function occurs
in severe cases as a result of hemorrhagic necrosis of the
central grey matter, which begins within minutes of in-
jury. A very likely site of posttraumatic molecular dam-
age is the cell membrane that undergoes marked alter-
ations of integrity and function.2,3 Changes in lipid me-
tabolism may play an important role in delayed
secondary tissue damage.1
Demediuk and co-workers, who followed a seven-day
post-injury period, discovered that traumatic SCI results
in early, transient, post-injury membrane phospholipid
hydrolysis. In the second wave, more delayed and sus-
tained lipid hydrolysis occurs, the magnitude of which is
related to the severity of injury.1 Under our experimental
conditions, samples were taken 9 days after injury and
we still observed a 6-fold increase in free AA.48 This is
in line with the gradual spontaneous wound-healing pro-
cess that follows spinal cord injury and has been report-
ed by other authors.1,16
Under our experimental conditions, HBOT did not al-
ter spinal cord FFA levels of laminectomized animals. On
the contrary, when the rabbits with SCI were exposed to
HBOT immediately after injury and for eight consecu-
tive days, the treatment significantly prevented SCI-in-
duced increases in all measured FFAs. To our know-
ledge this is the first time that influence of HBOT on the
FFA level and cell membrane integrity has been reported
in a SCI model.
Our findings are in agreement with some earlier stu-
dies describing a beneficial effect of HBOT in SCI models.
HBOT has been reported to improve neurological recov-
ery following SCI.49 Potential mechanisms of HBOT are:
tissue protection (ameliorates the hypoxic state induced
by oedema and circulatory compromise after SCI, reduced
tissue oedema, preserves intracellular adenosine triphos-
phate, increases the flexibility of red blood cells, termi-
nates lipid peroxidation, prevents adherence of PMNs
(polymorphonuclear neutrophiles) to damaged endothe-
lial cells), wound repair and healing promotion (enhan-
ces neovascularization, stimulates fibroblast growth, in-
creases collagen deposition), as well as osteogenesis (sy-
nergistic effect with the osteoinduction effects of rhBM
P-2, enhances osteoclastic activity).50,51
Narayana and co-workers performed magnetic reso-
nance imaging (MRI) in order to assess the efficacy of
HBOT in experimental SCI in the rat.22 A moderately
severe injury was chosen for these studies. Improvement
in neurological recovery (based on the Tarlov scale)38
was observed following HBOT treatment over a period
of 72 h. Based on MRI data, HBOT appears to arrest the
spread of haemorrhage and resolves edema.22 Further-
more, Higgins and co-workers conducted a study of acute
effects of HBOT on long-tract function following spinal
cord trauma. Their observations suggested that HBOT
can preserve marginally injured neuronal elements of the
spinal cord long tracts during the early phases of trau-
matic SCI. These protective effects may be based on the
reversal of focal tissue hypoxia, or reduction of tissue
edema.52 More recently, Murakami and co-workers23
reported that shortly after ischemic injury HBOT has
protective effects against ischemic spinal cord damage,
though HBOT does not change the prognosis. This was
the first study that demonstrated the influence of HBOT
on delayed neuronal cell death in the spinal motor neu-
rons. Additionally, these authors have shown that if
HBOT is started 6 h after ischemic insults, it does not
exhibit any protective effects on the spinal motor neu-
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Figure 7. The effect of HBOT on the levels of free palmitic (C16:0),
stearic (C18:0), oleic (C18:1), arachidonic (C20:4) and docosa-
hexaenoic (C22:6) acids 9 days after the experimental spinal cord
injury in rabbits (INJURY-HBOT). Each column represents mean
± S.E.M.; n = 6 for each group; *p0.05; significantly different
from control group (INJURY).
rons.23 An earlier start of treatment is therefore neces-
sary. Later, Huang and co-workers discovered that multi-
ple HBOT in rats with SCI for up to 6 h after injury with
further serial HBOT administration is superior to a sin-
gle HBOT.49 Namely, the group of animals receiving a
single HBOT intervention beginning at 30 min and 3 h,
or serial HBOT starting at 6 h following the injury had a
significantly better neurological recovery than animals
with SCI only.49 In our study, animals were treated im-
mediately after the injury and for 8 consecutive days, pro-
viding a combination of the two most successful HBOT
regimens so far described49 in order to achieve a tissue
protective effect.
Delayed neuronal death observed by Murakami and
co-workers could be associated with the decrease in FFAs
observed in our experiment after treatment with HBOT
since neuronal cell integrity is essential for its function.23
SCI in our model seems to be a non-specific traumatic
injury causing a non-specific liberation of FFAs and
HBOT is able to prevent this non-specific membrane
phospholipid cleavage and the resulting disturbances in
cell homeostasis. Further detailed time-dependent changes
should be studied, and then linked to particular biochem-
ical changes.
The period after injury can be divided into three dif-
ferent therapeutic windows: biochemical and vascular
events, starting at the time of injury and continuing for
up to 48 h; the influence of inflammatory cells, starting
within hours of injury and peaking four days after in-
jury; and axonal regeneration and lesion repair starting
one week after injury.53
HBOT seems to act throughout all three therapeutic
windows. In the first phase, it induces vasoconstriction
(preventing oedema formation) and in parallel it provides
sufficient quantities of oxygen to the tissue (addressing
problem of tissue hypoxia and resulting reperfusion in-
jury), compensating for vascular insufficiency. Hence,
the cascade of biochemical events started by hypoxia,
Ca2+ influx and liberation of FFAs might be stopped, at
least partially at the very beginning.
Following an ischemic interval, secondary injury is
largely mediated by the inappropriate activation of leu-
kocytes. Neutrophils have been implicated in reperfusion
injury, which can worsen primary injury.17 Adhering to
the walls of ischemic vessels, they release proteases and
produce free radicals, causing pathological vasoconstric-
tion and extensive tissue destruction.54 Hyperbaric oxy-
gen inhibits neutrophil activation, adherence and posti-
schemic vasoconstriction in ischemic rat tissue.55,56
Further, it has been recognized that much of the post-
traumatic degeneration of the spinal cord following in-
jury is caused by biochemical events involving reactive
oxygen-induced lipid peroxidation.57 HBOT could be also
beneficial in this phase and antioxidant systems may be
involved in its mode of action, despite the apparent con-
tradiction in this statement.58 As a matter of fact, decreas-
ed levels of the peroxidation product malondialdehyde,
as well as increased activities of antioxidant enzymes, have
been reported in some animal models after HBOT. Thus,
Gulec and co-workers observed that malondialdehyde
levels in erythrocytes, plasma and intestinal tissue were
decreased and the levels of glutathione peroxidase (GPX)
and superoxide dismutase (SOD) were significantly in-
creased in rats with acute distal colitis treated with HBOT.
Furthermore, HBOT was accompanied by a significant
decrease in colonic weight, PGE2 generation, myelopero-
xidase, and NOS (nitric oxide synthase) activities in stu-
dies performed by another group.59
Contrary to these findings, prolonged exposure to oxy-
gen under increased atmospheric pressure is known to
produce significant toxic effects in a variety of body tis-
sues.60 However, the onset of such overt toxic manifes-
tations can be delayed when HBOT is administered in-
termittently.60 A number of studies suggest that pronounc-
ed levels of free radicals are only observed at high pres-
sures (>3 atm (303.975 kPa)) or after long HBOT expo-
sure.61 Also, it has been reported that exposing rats to 4
atm (405.300 kPa) of oxygen for 90 min was associated
with an increased level of lipid peroxidation products and
that it altered enzymatic GPX in brain49 and 100 % oxygen
at 5 atm (506.625 kPa) produced seizures.62 Free radicals
were also observed when rats were exposed to HBOT for
48 hours.63 In contrast, Dennong et al.64 showed that
HBOT (2.5 atm (253.313 kPa) 3 x 30 min) did not gen-
erate detectable free radical levels in humans, and Mink
and Dutka62 demonstrated that HBOT at low pressure (2.8
atm (283.710 kPa) for 75 min) was not associated with
an increase in lipid peroxidation in a global cerebral ische-
mic model in rabbits despite increased amounts of free
radicals in brain.49 Nylander and co-workers reported that
lipid peroxidation did not occur with the pressure and
exposure time commonly employed in routine HBOT.65
Since we used 2.2 atm (222.915 kPa) for 45 min in-
termittently during our procedure and the motor score was
significantly improved in HBOT rabbits vs. non-treated
rabbits, we believe that it is more likely that the decrease
in FFAs in our experiment is a result of decreased libera-
tion from cell membranes and not of their greater oxida-
tion into hydroxyl acids and isoprostanes. In this experi-
ment, the decrease in FFAs observed could be a combined
result of several elements of HBOT, such as prevention
of the hypoxia-induced cascade of membrane degrada-
tion and free radical formation, inactivation of neutro-
phils and potentiation of antioxidant tissue mechanisms.
We have observed similar dose-dependent decrease in
FFAs after indomethacin treatment in this model of SCI.66
CONCLUSIONS
Under our experimental conditions, experimental SCI
induced a significant increase in all the measured FFAs:
palmitic, stearic, oleic, arachidonic and docosahexaenoic
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acids. HBOT applied immediately after injury and fol-
lowed by 8 consecutive daily treatments prevented the
SCI-induced increase in spinal cord FFAs.
These data suggest that a perturbation of membrane
lipid metabolism may contribute to the tissue necrosis and
functional deficit associated with a SCI, and HBOT may
protect the injured spinal cord tissue, at least in part, by
limiting these posttraumatic membrane lipid changes.
Additionally, these results suggest that HBOT atte-
nuates hypoxia-induced changes in the spinal cord tissue
after injury and could be an adjunct in its treatment.
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SA@ETAK
Utjecaj hiperbari~ne oksigenacije na razinu slobodnih masnih kiselina
u eksperimentalnome modelu kontuzije le|ne mo`dine kuni}a
Radojka Pantovi}, Pero Dragani}, Vesna Erakovi}, Branka Blagovi}, ^edomila Milin i Ante Simoni}
Cilj ovoga rada bio je istra`iti utjecaj hiperbari~ne oksigenacije, potentnoga sredstva korekcije hipoksije,
na motori~ku aktivnost kuni}a s povredom le|ne mo`dine i koncentraciju slobodnih masnih kiselina (FFA, free
fatty acid) u uzorcima tkiva povrije|ene mo`dine, i to palmitinske (C16:0), stearinske (C18:0), oleinske
(C18:1n-9), arahidonske (C20:4n-6) i dokozaheksaenske (C22:6n-3). Rezultat eksperimentalne povrede le|ne
mo`dine je te{ki motori~ki deficit u kuni}a, ali i akumulacija svih analiziranih FFA. Hiperbari~na oksigenacija
(HBOT), terapija udisanjem 100 % kisika u uvjetima povi{enog tlaka (222.915 kPa kroz 45 minuta) neposredno
nakon povrede te jo{ 8 uzastopnih dana, popravila je motori~ko o{te}enje i u potpunosti zaustavila porast kon-
centracije FFA uzrokovan povredom. Ovi podaci ukazuju da poreme}aj u metabolizmu membranskih lipida mo`e
doprinijeti funkcionalnome deficitu, koji je posljedica povrede le|ne mo`dine, kao i da HBOT mo`e za{tititi
povrije|eno tkivo, ograni~avaju}i posttraumatske promjene membranskih lipida.
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